Fig. 3From: SGLT-2 inhibitors and cardiorenal outcomes in patients with or without type 2 diabetes: a meta-analysis of 11 CVOTsForest plots examining the composite outcome of cardiovascular death or hospitalization for heart failure in participants of four CVOTs with (top) or without (bottom) type 2 diabetes. There is no heterogeneity in the analyses (I2 = 0%) and difference between the two groups (P interaction = 0.81)Back to article page